Objective—
This study aimed to determine the potential impact of type 2 diabetes mellitus on left ventricular dysfunction and the development of calcified aortic valve disease using a dyslipidemic mouse model prone to developing type 2 diabetes mellitus.
Approach and Results—
When compared with nondiabetic LDLr
−/−
/ApoB
100/100
, diabetic LDLr
−/−
/ApoB
100/100
/IGF-II mice exhibited similar dyslipidemia and obesity but developed type 2 diabetes mellitus when fed a high-fat/sucrose/cholesterol diet for 6 months. LDLr
−/−
/ApoB
100/100
/IGF-II mice showed left ventricular hypertrophy versus C57BL6 but not LDLr
−/−
/ApoB
100/100
mice. Transthoracic echocardiography revealed significant reductions in both left ventricular systolic fractional shortening and diastolic function in high-fat/sucrose/cholesterol fed LDLr
−/−
/ApoB
100/100
/IGF-II mice when compared with LDLr
−/−
/ApoB
100/100
. Importantly, we found that peak aortic jet velocity was significantly increased in LDLr
−/−
/ApoB
100/100
/IGF-II mice versus LDLr
−/−
/ApoB
100/100
animals on the high-fat/sucrose/cholesterol diet. Microtomography scans and Alizarin red staining indicated calcification in the aortic valves, whereas electron microscopy and energy dispersive x-ray spectroscopy further revealed mineralization of the aortic leaflets and the presence of inflammatory infiltrates in diabetic mice. Studies showed upregulation of hypertrophic genes (
anp
,
bnp
,
b-mhc
) in myocardial tissues and of osteogenic genes (
spp1
,
bglap
,
runx2
) in aortic tissues of diabetic mice.
Conclusions—
We have established the diabetes mellitus –prone LDLr
−/−
/ApoB
100/100
/IGF-II mouse as a new model of calcified aortic valve disease. Our results are consistent with the growing body of clinical evidence that the dysmetabolic state of type 2 diabetes mellitus contributes to early mineralization of the aortic valve and calcified aortic valve disease pathogenesis.